It’s the start of January. You’re just settling back into work after the holidays, maybe your kids just went back to school after a long break, and if you’re in biotech, you might be packing your bags for the J.P. Morgan Healthcare Conference in San Francisco.
JPM week, the “Super Bowl of biotech” as some call it, is a yearly tradition for many in the industry (and those who cover it). The conference is unique in that often more action happens beyond the walls of the Westin St. Francis than happens within them. But without fail, companies merge or get acquired, deals get done, and people regret not bringing an umbrella or packing more comfortable shoes.
One thing that’s different, from last year anyway, is the mood going into the conference. In this week’s STATus Report, host Alex Hogan chats with STAT reporters Allison DeAngelis and Damian Garde about what they’ll be keeping an eye out for at JPM 2026, and why the vibes have shifted.
